A West Coast biotech entrepreneur has secured $30 million to establish Preventive, a public-benefit company aimed at researching heritable genome editing. This controversial practice involves modifying embryos to prevent genetic diseases, igniting debates around ethics and legality, as seen with past research incidents leading to imprisonment.
Additionally, the startup Still Bright aims to address rising copper demand with a less polluting production method. By utilizing water-based reactions derived from battery technology, they hope to refine copper while reducing environmental impact. This innovation seeks to alleviate pressures on the copper supply chain and promote cleaner industrial practices, contributing to broader sustainability efforts in technology sectors.
👉 Pročitaj original: MIT Technology Review – AI
